Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience.

scientific article

Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00381-015-2623-8
P698PubMed publication ID25749900
P5875ResearchGate publication ID273324251

P50authorTai-Tong WongQ38641665
Yu-Wen HuQ54678697
P2093author name stringYi-Wei Chen
Kai-Ping Chang
Hsin-Hung Chen
Feng-Chi Chang
Yi-Yen Lee
Wan-Yuo Guo
Muh-Lii Liang
Donald Ming-Tak Ho
Sang-Hue Yen
I-Chun Lai
Cheng-Ying Shiau
P2860cites workNew guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of CanadaQ27860904
Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor StudyQ28296725
Intracranial germ-cell tumors in childrenQ33335031
Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children's Oncology GroupQ33863188
Pediatric central nervous system germ cell tumors: a reviewQ34012518
Controversies in the management of intracranial germ cell tumors.Q36439649
SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation fQ36866034
Update on current standard treatments in central nervous system germ cell tumorsQ37795525
Delayed diagnosis in children with intracranial germ cell tumorsQ38125017
Intracranial germ-cell tumors: natural history and pathogenesisQ39495486
Treatment of germ cell tumors in the pineal regionQ42453836
Chemotherapy with cisplatin for AFP-secreting germ-cell tumors of the central nervous systemQ42487343
Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study.Q43197920
Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer GroupQ43444624
Combined chemotherapy and radiation therapy for CNS germ cell tumors--the Japanese experienceQ44465717
Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumorsQ44767134
Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocolQ44780578
AFP/beta-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89.Q46431239
The 2007 WHO Classification of Nervous System Tumors: newly recognized members of the mixed glioneuronal groupQ48122879
Prognosis of intracranial germ cell tumours: Effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16)Q48391650
Evidence of changes in regional blood perfusion in human intracranial tumours during conductive interstitial hyperthermiaQ48417096
An attempt to treat pediatric intracranial alphaFP and betaHCG secreting germ cell tumors with chemotherapy alone. SFOP experience with 18 cases. Société Française d'Oncologie PédiatriqueQ48497303
Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapyQ48793236
Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified casesQ48794091
Change in treatment strategy for intracranial germinoma: long-term follow-up experience at a single instituteQ48849587
The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumorsQ48919893
Predictive value of marker half-life in relapsed and nonrelapsed nonseminomatous germ cell testicular tumor patients undergoing chemotherapy.Q53126862
Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.Q53286536
Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy.Q53326085
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.Q53576437
[Cisplatin, vinblastine and bleomycin (PVB) combination chemotherapy in the treatment of intracranial malignant germ cell tumors--a preliminary report of a phase II study--The Japanese Intracranial Germ Cell Tumor Study Group]Q68976833
Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89Q80156987
P433issue5
P304page(s)683-691
P577publication date2015-03-08
P1433published inChild's Nervous SystemQ15762919
P1476titleTreatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience
P478volume31

Reverse relations

cites work (P2860)
Q47646794Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors
Q92433375Immature teratoma of the posterior fossa in an infant: case report
Q55082765Intracranial Germ Cell Tumor in the Molecular Era.

Search more.